Today: 2 March 2026
Browse Category

Mergers & Acquisitions 16 October 2025 - 25 October 2025

Grindr Stock Skyrockets on Buyout Buzz – What Investors Need to Know

Grindr (GRND) Stock Explodes on $18 Buyout Buzz – Is a $3.5B Takeover Coming?

Grindr shares jumped 18.9% to $15.06 on Oct 24 after Chairman James Lu and investor Ray Zage, who control over 60% of the company, proposed taking it private at $18 per share. The board formed a special committee to review the offer. Trading volume surged to about 11.4 million shares. Two law firms launched investigations into possible breaches of fiduciary duty.
Grindr Stock Skyrockets on Buyout Buzz – What Investors Need to Know

Grindr Stock Skyrockets on Buyout Buzz – What Investors Need to Know

Grindr shares surged over 25% on October 24 after its two largest shareholders proposed an $18 per share buyout, valuing the company at a 51% premium to pre-offer prices. Board chair James Lu and director Ray Zage, controlling about 60% of shares, submitted the non-binding bid and say financing is secured. Grindr’s board formed a special committee to review the offer. Trading volume spiked to nearly 6 million shares.
Rocket Companies Stock Blasts Off After $14B Mega-Merger – Will RKT Keep Soaring?

Rocket Companies Stock Blasts Off After $14B Mega-Merger – Will RKT Keep Soaring?

Rocket Companies closed a $14.2 billion acquisition of Mr. Cooper Group on Oct. 1, the largest mortgage merger to date. RKT stock trades near $17, up about 80% year-to-date but below its early October high of $22.56. Shares have rallied 50% since the merger was announced in March, with short interest at 57%. Q3 earnings are due Oct. 30, with analysts expecting EPS of $0.04, down 50% year-over-year.
Avadel Stock Rockets on $2.1B Alkermes Buyout Offer – Key Developments & Analyst Takeaways

Avadel Stock Rockets on $2.1B Alkermes Buyout Offer – Key Developments & Analyst Takeaways

Alkermes will acquire Avadel for $18.50 per share in cash, plus a $1.50 contingent payout, valuing the deal at about $2.1 billion. Avadel’s LUMRYZ sales are projected at $265–$275 million in 2025, with 3,100 patients on therapy. AVDL shares surged to near a 52-week high after the Jazz settlement and Alkermes news. Halper Sadeh LLC is investigating whether the offer undervalues Avadel.
Media Shakeup: Warner Bros. Discovery Mulls Sale After Blockbuster Bids

Media Shakeup: Warner Bros. Discovery Mulls Sale After Blockbuster Bids

Warner Bros. Discovery confirmed its board is reviewing strategic alternatives after receiving takeover interest, including a reported $20/share bid from Paramount Skydance that was rejected as too low. Shares jumped up to 9% pre-market on the news. Options include a full sale, spin-off, or division sales. CEO David Zaslav said the review aims to maximize shareholder value.
Blackstone & TPG in $18B Hologic Takeover Shock – Women’s Health Stock Skyrockets

Blackstone & TPG in $18B Hologic Takeover Shock – Women’s Health Stock Skyrockets

Blackstone and TPG will acquire Hologic for $76 per share in cash plus a contingent value right worth up to $3, valuing the deal at $18.3 billion including debt. Hologic’s board approved the offer, which represents a 46% premium to its pre-deal price. Abu Dhabi Investment Authority and Singapore’s GIC will co-invest. Hologic shares rose about 7% on the news; the deal is expected to close in the first half of 2026.
AlphaVest (ATMV) Rockets on AMC Robotics Merger Buzz – Key Facts & Forecast

AlphaVest (ATMV) Rockets on AMC Robotics Merger Buzz – Key Facts & Forecast

AlphaVest Acquisition shareholders approved a merger with AMC Corporation on Sept 5, including $8 million in PIPE financing. Investors later allowed up to four one-month deadline extensions, each requiring a $55,000 deposit. About 1.513 million shares were redeemed, removing $18.2 million from the trust. ATMV shares spiked from $8.8 to $13 in pre-market trading on Oct 21 amid merger rumors.
DocGo (NASDAQ: DCGO) Stock Rockets After Virtual Care Acquisition – Can the Rally Last?

DocGo (NASDAQ: DCGO) Stock Rockets After Virtual Care Acquisition – Can the Rally Last?

DocGo shares rose over 34% in after-hours trading Oct. 20, 2025, after announcing it will acquire telehealth provider SteadyMD using cash on hand. DocGo reported Q2 revenue of $80.4 million, down 51% year-over-year, and a net loss of $13.3 million. The company ended Q2 with $128.7 million in cash. A 2023 securities fraud lawsuit against DocGo remains active.
Sirius XM Stock Shocks Wall Street: Buffett’s Big Bet, Liberty Merger Fallout & 2025 Streaming Showdown

Sirius XM Stock Shocks Wall Street: Buffett’s Big Bet, Liberty Merger Fallout & 2025 Streaming Showdown

Sirius XM traded near $21.30 on October 20, 2025, steady after recent volatility. Berkshire Hathaway now owns about 37% of shares following a Liberty Media merger, though this represents just 1% of its portfolio. Q3 earnings are due October 30, with analysts expecting $0.79 EPS on $2.14 billion revenue. Wall Street targets range widely, with the average near $23 per share.
Biotech Breakthrough: Rani Therapeutics (RANI) Stock Skyrockets on $1B Deal – What Investors Need to Know

Rani Therapeutics (RANI) Stock Nearly Triples on $1B Chugai Deal – What Investors Should Know

Rani Therapeutics shares surged 248% to close at $1.64 on Oct. 17 after announcing a collaboration with Chugai Pharmaceutical worth up to $1.08 billion. The deal includes $10 million upfront and up to $175 million in milestones for the first drug. Rani also raised $60.3 million in a private placement, extending its cash runway into 2028. The company’s RaniPill technology delivers injectable drugs via oral capsules.
GitLab Stock Rockets 11% on Datadog Buyout Buzz – AI Moves and Analyst Reactions

GitLab Stock Rockets 11% on Datadog Buyout Buzz – AI Moves and Analyst Reactions

GitLab shares surged 11% to $48.27 on October 16 after reports that Datadog is considering a takeover bid above $60 per share. Trading volume soared to nearly 19 million shares, about seven times normal levels. The rally ended a two-week slide triggered by tech sector volatility and concerns over GitLab’s recent earnings and CFO departure.
GitLab Stock Soars 11% on Datadog Takeover Rumors Amid AI DevOps Boom

GitLab Stock Soars 11% on Datadog Takeover Rumors Amid AI DevOps Boom

GitLab shares jumped 11% to $48.27 on Oct. 16 after reports that Datadog is considering a $60-plus per share takeover. Nearly 19 million shares changed hands, about seven times normal volume. The rally ended a two-week slide triggered by conservative guidance and the CFO’s planned departure. Wall Street remains divided, with price targets ranging from $50 to $72.
CSX CEO Abruptly Departs Amid Rail Merger Frenzy – What’s Next?

CSX Delivers Earnings Surprise: Stock Jumps as New CEO Navigates Rail Merger Frenzy

CSX shares rose about 3% to $36–$37 after reporting adjusted Q3 profit of $0.44 per share, beating expectations. Revenue matched forecasts at $3.59 billion as higher intermodal volumes offset weak coal demand. Net income fell 22% year-over-year due to one-time charges. The report marked Steve Angel’s first quarter as CEO following a recent leadership shakeup.
BBVA Stock Jumps on Failed Takeover Bid – What’s Next for the Banking Giant?

BBVA Stock Jumps on Failed Takeover Bid – What’s Next for the Banking Giant?

BBVA’s €16 billion hostile takeover bid for Sabadell collapsed after only 25.5% of shares were tendered, below the required threshold. BBVA stock jumped on relief, with U.S.-listed ADRs surging 6–7% intraday on Oct. 16 as trading volume spiked. All major rating agencies upgraded BBVA in recent weeks, citing strong profits and capital. The bank announced a record interim dividend and will resume €1 billion in buybacks Oct. 31.
Capital One Savers Cheated Out of Billions – $425M Settlement Payout Deadline Fast Approaching

Capital One Stock Plunges 6% Amid Settlement Showdown, Big Merger & Earnings Countdown

Capital One shares fell 5.9% to $202.42 on Oct. 16, erasing a week’s gains after legal and sector concerns. The drop follows a rally to $215 the day before. The bank faces scrutiny over a $425 million settlement and reports Q3 earnings Oct. 21. Capital One completed its $35.3 billion Discover takeover in May, becoming the largest U.S. card issuer.
Omeros Stock Explodes 146% on Surprise $2.1B Novo Nordisk Deal – What Comes Next?

Biotech Bombshell: Omeros Stock Skyrockets on $2.1B Novo Nordisk Deal – What’s Next?

Omeros shares soared 150% to $10.42 on Oct. 15 after Novo Nordisk agreed to license its drug zaltenibart (OMS906) for $340 million upfront and up to $2.1 billion in milestones and royalties. Trading volume hit 89.2 million shares, far above average. Omeros reported a Q2 net loss of $25.4 million and $28.7 million in cash as of June 30. Its lead asset narsoplimab remains under FDA and EMA review.
First Horizon (FHN) Stock Shocker: CEO’s Merger Hint Sends Shares Tumbling 13%

First Horizon (FHN) Stock Shocker: CEO’s Merger Hint Sends Shares Tumbling 13%

First Horizon shares plunged 13% to about $20 on Oct. 15, 2025, the steepest drop since May 2023, after M&A comments on its earnings call. The bank beat Q3 expectations with adjusted EPS of $0.51 and $889 million in revenue. Analysts raised some price targets but trimmed others; consensus sits near $25.3. FHN’s drop contrasted with a rally in other U.S. bank stocks that day.
Go toTop